Adimab, Inc. Receives $6,000,000 Series A Round
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=ad20375f-027b-442f-8997-ec7e5dfce8f8&Preview=1 -
Date
7/20/2007 -
Company Name
Adimab, Inc. -
Mailing Address
16 Cavendish Court Lebanon, NH 03766 -
Company Description
Adimab–which stands for Antibody Discovery Maturation Biomanufacturing–is developing a platform that’s deliberately engineered to minimize and potentially eliminate third party royalties, offering a one-stop-service-shop to a select few Big Pharma partners. -
Website
http://www.adimab.com -
Transaction Type
Venture Equity -
Transaction Amount
$6,000,000 -
Transaction Round
Series A -
Proceeds Purposes
Proceeds purposes were not disclosed. -
M&A Terms
-
Venture Investor
SV Life Sciences -
Venture Investor
Polaris Venture Partners
